This is supported by observations that NHB women have higher mortality rates than NHW women, even when detected with the Luminal (ER + PR + and Her2 + or –) subtypes, which have the best prognostic outcomes of any breast cancer subtype [18–20]. This evidence concerns the gene PGR and breast carcinoma.